Rankings
▼
Calendar
RGEN Q3 2020 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena
RGEN
Repligen Corporation
$7B
Q3 2020 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$94M
+35.4% YoY
Gross Profit
$54M
57.9% margin
Operating Income
$22M
23.3% margin
Net Income
$15M
15.5% margin
EPS (Diluted)
$0.27
QoQ Revenue Growth
+7.5%
Cash Flow
Operating Cash Flow
$21M
Free Cash Flow
$16M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$1.5B
Total Liabilities
$351M
Stockholders' Equity
$1.1B
Cash & Equivalents
$553M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$94M
$69M
+35.4%
Gross Profit
$54M
$38M
+43.2%
Operating Income
$22M
$8M
+175.8%
Net Income
$15M
$2M
+777.2%
Revenue Segments
Product
$94M
100%
Royalty
$31,000
0%
← FY 2020
All Quarters
Q4 2020 →